Skip to main content

Hoth Therapeutics Inc. Common Stock (HOTH)

About The Company

HOTH Stock Market Logo

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

IPO Year Sector Industry
2019 Consumer Discretionary Specialty Chemicals

Hoth Therapeutics Inc. (HOTH) Latest News

Company Contact & Address (HOTH)

Corporate Headquarters Phone Website
New York,
United States
+1 646 756-2997 Official HOTH Website

HOTH Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Consumer Discretionary P/E Ratio Not Available
Industry Specialty Chemicals Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ HOTH

Jobs & Employment at Hoth Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs & Employment at Hoth Therapeutics Inc. (HOTH)

Related & Similar Stock Symbols

AUTO Stock Market Price & News


AutoWeb Inc. Common Stock

PFTA Stock Market Price & News


Portage Fintech Acquisition Corporation Class A Ordinary …

NILE Stock Market Price & News


BitNile Holdings Inc. Common Stock